The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
Ashley Chen, PharmD, BCOP
Advertisement
Articles by Ashley Chen, PharmD, BCOP
Pharmacists have an important role in the optimization of AML therapies.
Advertisement
Latest Updated Articles
Emerging Bispecific T-Cell Engagers in Myeloma: Promises and HurdlesPublished: April 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
5
